![Roland Kolbeck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 124 748 $ in data 31/07/2026
Dr. Roland Kolbeck is a Chief Scientific Officer at Aclaris Therapeutics, Inc. Dr. Kolbeck was previously employed as a Chief Scientific Officer by Spirovant Sciences, Inc. He received his graduate degree from the University of Regensburg.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/08/2026 | 23.990 ( 0,02% ) | 124 748 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 28/07/2025 |
| Società | Posizione | Fine |
|---|---|---|
Spirovant Sciences, Inc.
 Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Direttore Tecnico/Scientifico/R&S | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
University of Regensburg
 University of Regensburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spirovant Sciences, Inc.
Spirovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Engages in development, manufacturing of pharmaceuticals related to gene therapy | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
